| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/01/2011 | WO2011105570A1 Method for determining presence or absence of cancer cell in biological sample, and molecular marker and kit for determination |
| 09/01/2011 | WO2011105556A1 Marker for detection of myogenic diseases, and method for detection of the diseases using same |
| 09/01/2011 | WO2011105429A1 Site-specific recombination method and kit |
| 09/01/2011 | WO2011105424A1 Dendritic cell immunoreceptor stimulant |
| 09/01/2011 | WO2011105379A1 PROCESS FOR PRODUCTION OF POLYHYDROXYALKANOIC ACID USING GENETICALLY MODIFIED MICROORGANISM HAVING ENOYL-CoA HYDRATASE GENE INTRODUCED THEREIN |
| 09/01/2011 | WO2011105344A1 Process for production of cadaverine |
| 09/01/2011 | WO2011105335A1 Method for constructing novel bacterium belonging to the genus bifidobacterium |
| 09/01/2011 | WO2011105241A1 Method for producing glucuronic acid conjugate using saccharomyces cerevisiae |
| 09/01/2011 | WO2011105071A1 Method for screening nucleic acid ligand |
| 09/01/2011 | WO2011104758A1 Method for amplifying target sequence within double-stranded dna |
| 09/01/2011 | WO2011104687A1 Antagonist anti-il-7 receptor antibodies and methods |
| 09/01/2011 | WO2011104169A1 Compositions for targeted delivery of sirna |
| 09/01/2011 | WO2011104155A2 Plants having enhanced yield-related traits and a method for making the same |
| 09/01/2011 | WO2011104153A1 Nematode-resistant transgenic plants |
| 09/01/2011 | WO2011104143A1 Plants having enhanced yield-related traits and a method for making the same |
| 09/01/2011 | WO2011104141A1 Plants having enhanced yield-related traits and a method for making the same |
| 09/01/2011 | WO2011104128A2 Plants having enhanced yield-related traits and a method for making the same |
| 09/01/2011 | WO2011104032A1 Method for isolating rna from a rna and dna containing sample |
| 09/01/2011 | WO2011104027A1 Process for parallel isolation and/or purification of rna and dna |
| 09/01/2011 | WO2011103770A1 Kit for quantitative detection of braf mutation |
| 09/01/2011 | WO2011103714A1 Genes conferring stress tolerance in plants and uses thereof |
| 09/01/2011 | WO2011103702A1 Fully human monoclonal antibody to vegf, preparation method and use thereof |
| 09/01/2011 | WO2011103700A1 Fully humanized anti-her2 antibody, preparation method and use thereof |
| 09/01/2011 | WO2011103666A1 Modulation of cytokine-induced chronic inflammatory responses |
| 09/01/2011 | WO2011085367A3 Non-replicating microorganisms as post-biotics |
| 09/01/2011 | WO2011082310A3 Methods and compositions for targeted polynucleotide modification |
| 09/01/2011 | WO2011070440A3 Oncolytic rhabdovirus |
| 09/01/2011 | WO2011043584A9 Highly pathogenic avian influenza virus protein vaccine derived from transgenic plants, and method for preparing same |
| 09/01/2011 | WO2011034406A3 Rhodanobacter ginsenosidimutans kctc22231t-derived ginsenoside glycosidase, and use thereof |
| 09/01/2011 | WO2011034402A3 Enhancement of the effects of soluble recombinant human rank using point mutations, and bone disease treatment composition using same |
| 09/01/2011 | WO2010147372A9 Primer and probe for detecting malaria plasmodium and detection method using same |
| 09/01/2011 | WO2010127195A3 Treatment of hemoglobin (hbf/hbg) related diseases inhibition of natural antisense transcript to hbf/hbg |
| 09/01/2011 | US20110214207 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same |
| 09/01/2011 | US20110214206 Nucleic acid molecules and other molecules associated with plants |
| 09/01/2011 | US20110214204 Polynucleotides encoding proteins involved in plant metabolism |
| 09/01/2011 | US20110214203 Sugar and lipid metabolism regulators in plants ii |
| 09/01/2011 | US20110214202 CVYV-Resistant Plants of the Species Cucumis Melo |
| 09/01/2011 | US20110214199 Genes and uses for plant enhancement |
| 09/01/2011 | US20110214192 Photoconvertible fluorescent proteins |
| 09/01/2011 | US20110213337 Methods for the early diagnosis of ovarian cancer |
| 09/01/2011 | US20110213136 Antisense modulation of stearoyl-coa desaturase expression |
| 09/01/2011 | US20110213130 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 09/01/2011 | US20110213128 Sirna capable of inhibiting the expression of an oncogene involved in cervical cancer |
| 09/01/2011 | US20110213018 Compositions and methods for regulation of smooth muscle cells and blood pressure |
| 09/01/2011 | US20110213015 Oligonucleotidic sequences able to silence the expression of the cyclin d1-trop2 chimera and uses thereof in medical field |
| 09/01/2011 | US20110213014 Compositions and methods for topical delivery of oligonucleotides |
| 09/01/2011 | US20110213007 MicroRNAs and uses thereof |
| 09/01/2011 | US20110213005 Methods for treating viral infections |
| 09/01/2011 | US20110212981 Method of Determining a Chemotherapeutic Regimen Based on ERCC1 and TS Expression |
| 09/01/2011 | US20110212859 Radio frequency identifiers for use in biological science |
| 09/01/2011 | US20110212857 Multiplexed Assay Using Encoded Solid Support Matrices |
| 09/01/2011 | US20110212843 Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting ap-1 transcription factors |
| 09/01/2011 | US20110212838 Sulfonylurea-Responsive Repressor Proteins |
| 09/01/2011 | US20110212530 Method of targeted gene delivery using viral vectors |
| 09/01/2011 | US20110212529 Muscle-specific expression vectors |
| 09/01/2011 | US20110212528 Novel substitution mutant receptors and their use in an ecdysone receptor-based inducible gene expression system |
| 09/01/2011 | US20110212527 Method to increase the production of extracellular polymeric substances (eps) in a acidithiobacillus ferrooxidans culture by the inhibition of enzymes of tricarboxilic acid cycle |
| 09/01/2011 | US20110212526 Method for producing recombinant adeno-associated virus |
| 09/01/2011 | US20110212520 Rna interference suppression of neurodegenerative diseases and methods of use thereof |
| 09/01/2011 | US20110212518 Expression vector and methods of producing high levels of proteins |
| 09/01/2011 | US20110212508 Novel Synthetic Expression Vehicle |
| 09/01/2011 | US20110212506 Nitrile hydratase variant |
| 09/01/2011 | US20110212505 BGL3 Beta-Glucosidase and Nucleic Acids Encoding the Same |
| 09/01/2011 | US20110212502 [NiFe]-Hydrogenases Having an Improved Resistance to Dioxygen, Process for Obtaining Them and Their Applications |
| 09/01/2011 | US20110212493 Perfusion bioreactors, cell culture systems, and methods for production of cells and cell-derived products |
| 09/01/2011 | US20110212458 Methods for Production of Xylitol in Microorganisms |
| 09/01/2011 | US20110212457 Methods and compositions for determining the pathogenic status of infectious agents |
| 09/01/2011 | US20110212452 Method for preparative production of long nucleic acids by pcr |
| 09/01/2011 | US20110212449 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues |
| 09/01/2011 | US20110212252 Plants and seeds of spring canola variety scv431158 |
| 09/01/2011 | US20110212249 Nucleotide sequences and corresponding polypeptides conferring modulated plant size and biomass and other characteristics in plants |
| 09/01/2011 | US20110212248 Plants and seeds of spring canola variety scv470336 |
| 09/01/2011 | US20110212247 Plants and seeds of spring canola variety scv453784 |
| 09/01/2011 | US20110212241 Modified amylases, nucleic acids encoding those amylases and uses thereof |
| 09/01/2011 | US20110212223 Mutants of lactobacillus casei defective in carbon catabolism regulation |
| 09/01/2011 | US20110212164 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 09/01/2011 | US20110212162 Lymphatic zip codes in tumors and pre-malignant lesions |
| 09/01/2011 | US20110212134 Anti-arthropod vector vaccines, methods of selecting and uses thereof |
| 09/01/2011 | US20110212130 Live, attenuated respiratory syncytial virus |
| 09/01/2011 | US20110212120 Ykur polynucleotides and polypeptides |
| 09/01/2011 | US20110212117 Influenza hemagglutinin and neuraminidase variants |
| 09/01/2011 | US20110212116 Immunogenic peptides and uses thereof |
| 09/01/2011 | US20110212115 Melk epitope peptides and vaccines containing the same |
| 09/01/2011 | US20110212109 Abeta CONFORMER SELECTIVE ANTI-Abeta GLOBULOMER MONOCLONAL ANTIBODIES |
| 09/01/2011 | US20110212108 Neuregulin/erbb signaling and integrin |
| 09/01/2011 | US20110212106 Hiv-1 neutralizing antibodies and uses thereof |
| 09/01/2011 | US20110212098 Novel Melanoma Antigen Peptide and Uses Thereof |
| 09/01/2011 | US20110212094 Dual variable domain immunoglobulins and uses thereof |
| 09/01/2011 | US20110212073 Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs |
| 09/01/2011 | US20110212070 Methods of differentiating and protecting cells by modulating the p38/mef2 pathway |
| 09/01/2011 | US20110212059 Paramyxovirus vector encoding angiogenesis gene and use thereof |
| 09/01/2011 | US20110212058 Targeted modulation of gene expression |
| 09/01/2011 | US20110212055 Neurodegenerative disorders |
| 09/01/2011 | US20110212030 Nucleic Acid Ligand Complexes |
| 09/01/2011 | US20110212028 Chemically modified cell-penetrating peptides for improved delivery of gene modulating compounds |
| 09/01/2011 | US20110212023 TADG-15: an extracellular serine protease overexpossed in carcinomas |
| 09/01/2011 | US20110212021 Targeted oligonucleotide compositions for modifying gene expression |
| 09/01/2011 | US20110210272 Methods and Products for Analyzing Polymers |
| 09/01/2011 | CA2825984A1 Method of making nucleic acid libraries |
| 09/01/2011 | CA2796586A1 Apparatus and methods for integrated sample preparation, reaction and detection |